Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Glucose Health's EBITDA for the
three
months ended in Sep. 2023 was $-0.06 Mil. Glucose Health's Revenue for the
three
months ended in Sep. 2023 was $0.11 Mil. Therefore, Glucose Health's EBITDA margin for the quarter that ended in Sep. 2023 was -52.79%.
Glucose Health (OTCPK:GLUC) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Glucose Health EBITDA Margin % Related Terms
Glucose Health EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Glucose Health's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GLUC vs RTON, BDPT, SMFL: EBITDA Margin % Comparison
For the Packaged Foods subindustry, Glucose Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glucose Health EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Glucose Health's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Glucose Health's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glucose Health (GLUC) has a EBITDA Margin % of -52.79% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Glucose Health and its competitors.
Is Glucose Health's EBITDA Margin % too high?
Glucose Health's current EBITDA Margin % is -52.79%. Overall, Glucose Health has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Glucose Health's EBITDA Margin % compare to RTON and BDPT?
Glucose Health's EBITDA Margin % of -52.79% can be compared against companies in the Consumer Packaged Goods industry. The industry median EBITDA Margin % is 8.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.92, based on 1,974 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Glucose Health and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glucose Health's current EBITDA Margin % is -52.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glucose Health stock overvalued right now?
Glucose Health (GLUC) has a current EBITDA Margin % of -52.79%. The current EBITDA Margin % is -52.79%. Glucose Health's overall GF Score™ is 38/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Glucose Health (GLUC), the current EBITDA Margin % is -52.79% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Glucose Health Inc is an own-label distributor of nutritional beverages. Its niche is the formulation, manufacturing, marketing, and distribution of soluble fiber-infused nutritional beverages. The Company has identified two underserved consumer markets and has launched two brands to serve these markets, which are GlucoDown and FIBER UP. The Company currently has one single operating and reporting segment, which is the manufacturing and distribution of nutritional beverages. It generates all of its revenue from sales of nutritional beverages. The beverages are sold through the Company's website as well as through retailers.
38GF Score
Get the complete analysis for GLUC
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLUC has been successfully added to your 
